Product Information
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Accord Healthcare Inc., priced at $0.6746 per EA under NDC 16729004301. Its NADAC has been published 643 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729004301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA091195On Market Since
9/30/2011
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has been published 643 times since Nov 28, 2013, and over the history we have for it it has declined 93.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6746 per EA |
|---|---|
| All-time high | $11.2888 (Dec 10, 2014) |
| All-time low | $0.6713 (Apr 22, 2026) |
| 52-week high | $0.9577 |
| 52-week low | $0.6713 |
| Median price | $2.0759 |
| Average price | $3.0757 |
| Largest weekly change | +172.0% (Dec 13, 2017) |
| Weeks tracked | 643 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Accord Healthcare Inc., is $0.6746 per EA (NDC 16729004301), effective May 20, 2026.
How has the price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has declined 93.1%. It has been tracked across 643 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 28, 2013, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.6713 (Apr 22, 2026) to a high of $11.2888 (Dec 10, 2014), with a median of $2.0759 per EA.
Are there cheaper alternatives to TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), is $0.6505 per EA — about 4% below TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE).
Who manufactures TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 16729004301) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification